Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 3
1960 11
1961 13
1962 6
1964 2
1965 10
1966 10
1967 3
1968 16
1969 16
1970 11
1971 8
1972 7
1973 3
1974 3
1975 4
1976 5
1977 3
1978 13
1979 12
1980 16
1981 17
1982 27
1983 15
1984 11
1985 16
1986 8
1987 10
1988 11
1989 21
1990 14
1991 28
1992 45
1993 30
1994 27
1995 52
1996 90
1997 83
1998 86
1999 82
2000 59
2001 58
2002 72
2003 79
2004 63
2005 73
2006 72
2007 72
2008 84
2009 79
2010 87
2011 82
2012 95
2013 120
2014 105
2015 113
2016 80
2017 70
2018 99
2019 86
2020 89
2021 54
2022 48
2023 57
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

2,523 results

Results by year

Filters applied: . Clear all
Page 1
[Perioperative dexamethasone].
Sinner B. Sinner B. Anaesthesist. 2019 Oct;68(10):676-682. doi: 10.1007/s00101-019-00672-x. Anaesthesist. 2019. PMID: 31595319 Review. German.
[Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting].
Kienbaum P, Schaefer MS, Weibel S, Schlesinger T, Meybohm P, Eberhart LH, Kranke P. Kienbaum P, et al. Anaesthesist. 2022 Feb;71(2):123-128. doi: 10.1007/s00101-021-01045-z. Epub 2021 Oct 1. Anaesthesist. 2022. PMID: 34596699 Review. German.
Aromatherapy for treatment of postoperative nausea and vomiting.
Hines S, Steels E, Chang A, Gibbons K. Hines S, et al. Cochrane Database Syst Rev. 2018 Mar 10;3(3):CD007598. doi: 10.1002/14651858.CD007598.pub3. Cochrane Database Syst Rev. 2018. PMID: 29523018 Free PMC article. Review.
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH. Hesketh PJ, et al. J Clin Oncol. 2017 Oct 1;35(28):3240-3261. doi: 10.1200/JCO.2017.74.4789. Epub 2017 Jul 31. J Clin Oncol. 2017. PMID: 28759346 Review.
Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, Hoshina Y, Sakata Y, Takahashi TY, Nakashima K, Nakao M, Takei D, Zenda S, Mizukami K, Iwasa S, Sakurai M, Yamamoto N, Ohe Y. Hashimoto H, et al. Lancet Oncol. 2020 Feb;21(2):242-249. doi: 10.1016/S1470-2045(19)30678-3. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838011 Clinical Trial.
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial.
Bajpai J, Kapu V, Rath S, Kumar S, Sekar A, Patil P, Siddiqui A, Anne S, Pawar A, Srinivas S, Bhargava P, Gulia S, Noronha V, Joshi A, Prabhash K, Banavali S, Sarin R, Badwe R, Gupta S. Bajpai J, et al. Lancet Oncol. 2024 Feb;25(2):246-254. doi: 10.1016/S1470-2045(23)00628-9. Epub 2024 Jan 12. Lancet Oncol. 2024. PMID: 38224701 Clinical Trial.
Olanzapine in oncology palliative care.
Šoukalová Z. Šoukalová Z. Klin Onkol. 2022 Summer;35(4):276-283. doi: 10.48095/ccko2022276. Klin Onkol. 2022. PMID: 35989084 Review. English.
2,523 results